Casma Therapeutics
PrivateLast Round
Grant
Mar 10, 2026
Total Funding Raised
$162.1M
Momentum Score
25 /100
Company Overview
Casma Therapeutics is a biotechnology company that focuses on harnessing the natural cellular process of autophagy to enhance drug discovery and development, targeting lysosomal storage disorders, muscle disorders, inflammatory disorders, and neurodegeneration to meet critical medical needs.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Casma Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Casma Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 10, 2026 | ||||
| Series C | Nov 15, 2022 | ||||
| Series B | Sep 10, 2020 | ||||
| Series A | May 3, 2018 |
Casma Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series C, Series B |
| Mirae Asset | Series C |
| Eventide Funds | Series C, Series B |
| The Chernin Group | Series C, Series B |
| Amgen Ventures | Series C |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| Astellas Venture Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
Secured $7.6M in grant funding.
- Jun 9, 2025
CSM-101 is in development for Parkinson's and Gaucher disease.
Casma Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Casma Therapeutics's valuation, stock price, and market status.
